Home/Filings/4/0001437749-24-003012
4//SEC Filing

Barrett Elizabeth A. 4

Accession 0001437749-24-003012

CIK 0001668243other

Filed

Feb 1, 7:00 PM ET

Accepted

Feb 2, 7:04 PM ET

Size

5.2 KB

Accession

0001437749-24-003012

Insider Transaction Report

Form 4
Period: 2024-01-31
Barrett Elizabeth A.
Chief Executive Officer
Transactions
  • Award

    Restricted Stock Units

    2024-01-31+87,61587,615 total
    Ordinary Shares (87,615 underlying)
Footnotes (2)
  • [F1]Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer.
  • [F2]1/3 of the shares underlying the restricted stock units will vest on each of January 31, 2025, January 31, 2026 and January 31, 2027.

Issuer

UroGen Pharma Ltd.

CIK 0001668243

Entity typeother

Related Parties

1
  • filerCIK 0001764157

Filing Metadata

Form type
4
Filed
Feb 1, 7:00 PM ET
Accepted
Feb 2, 7:04 PM ET
Size
5.2 KB